Synchronous colorectal carcinoma has seldom been studied in large series. The study was designed to examine the significance of colorectal synchronous carcinoma in a large cohort of patients.
The clinicopathological features of 102 patients with synchronous colorectal carcinoma were compared with 1,793 patients with solitary colorectal carcinoma.
The prevalence of synchronous colorectal carcinoma was 3.6%. In these patients, 4% had FAP, 6% had hyperplastic polyposis, and 2% had ulcerative colitis. The index carcinoma was more likely to have higher histological grade and T stage than other carcinoma(s) in the same patient. When compared with solitary colorectal carcinoma, synchronous colorectal carcinoma was more often noted in males with coexisting FAP and in proximal location. The 5-year survival rate of patients with synchronous colorectal carcinoma was 53% and was similar to those with solitary colorectal carcinoma.
We examined the clinicopathological features of patients with synchronous colorectal carcinomas in a large cohort of patients. Attention to these features was important for better management of this group of cancer.
To read this article in full you will need to make a payment
Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:Subscribe to The American Journal of Surgery
Already a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
- Synchronous colorectal cancer: not just bad luck?.Gastroenterology. 2009; 137: 1559-1562
- Epidemiology and prognosis of synchronous colorectal cancers.Br J Surg. 2008; 95: 1528-1533
- A comparison of multiple synchronous colorectal cancer in ulcerative colitis, familial polyposis coli, and de novo cancer.Ann Surg. 1986; 203: 123-128
- Differences in overall survival when colorectal cancer patients are stratified into new TNM staging strategy.Cancer Res. 2007; 39: 61-64
- Hyperplastic polyposis in the New Zealand population: a condition associated with increased colorectal cancer risk and European ancestry.N Z Med J. 2007; 120: U2827
- Clinical features, diagnosis, treatment and prognosis of multiple primary colorectal carcinoma.World J Gastroenterol. 2004; 10: 2136-2139
- Multiple colorectal tumors.Am J Surg. 1981; 142: 274-280
- Synchronous primary adenocarcinomas of the colon and rectum.Dis Colon Rectum. 1978; 21: 20-22
- Synchronous colorectal carcinoma: clinico-pathological features and prognosis.Jpn J Clin Oncol. 2003; 33: 38-43
- Multiple primary cancer: an experience at the Cancer Institute hospital with special reference to colorectal cancer.Int J Clin Oncol. 2003; 8: 162-167
- Evidence of a preferred molecular pathway in patients with synchronous colorectal cancer.Cancer. 2003; 98: 48-54
- Distribution of synchronous and metachronous multiple colorectal cancers.Hepato Gastroenterol. 2004; 51: 443-446
- Synchronous colorectal carcinomas.Hepatogastroenterology. 1994; 41: 409-412
- A prospective cohort study shows unique epigenetic, genetic, and prognostic features of synchronous colorectal cancers.Gastroenterology. 2009; 137: 1609-1620
- Prognosis in synchronous colorectal carcinomas.Z Gastroenterol. 1988; 26: 117-120
Published online: May 20, 2011
Received in revised form: April 25, 2010
Received: January 2, 2010
© 2011 Elsevier Inc. Published by Elsevier Inc. All rights reserved.